Clinical Trial

A Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of TIX100 in Healthy Subjects

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 30, 2025 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
A Single Center, Single Dose, Randomized, Placebo-controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
Trial Details
NCT Number NCT06800729
Lead Sponsor TIXiMED, Inc.
Conditions Healthy
Enrollment 35 participants
Start Date 2025-01
Primary Completion 2025-05 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2025-01-30